Mark Lampert‘s Biotechnology Value Fund recently filed a Form 13G with the SEC, in which it reported acquiring 4.58 million shares of Anthera Pharmaceuticals Inc (NASDAQ:ANTH), which amass 9.99% of the company’s outstanding stock. The acquisition represents a new addition to Biotechnology Value Fund’s portfolio.
Anthera Pharmaceuticals is a biopharmaceutical company engaged in discovering and producing a variety of therapeutics to treat severe disorders. The company has two product candidates in development, and it recently reported a positive DSMB review from its Phase 3 SOLUTION Study of Sollupra™. Since the beginning of the year, the company’s stock has lost 34.05%.
Out of the 749 hedge funds followed by Insider Monkey which filed 13Fs for the June 30 reporting period, nine investors were long Anthera Pharmaceuticals (NASDAQ:ANTH) at the end of the June quarter, down by one from the previous quarter. Some of the bullish investors contained Joseph Edelman’s Perceptive Advisors, which held a position worth $4.61 million, Kevin Kotler’s Broadfin Capital, with a position valued at $3.57 million, Kris Jenner, Gordon Bussard, Graham Mcphail’s Rock Springs Capital Management, Charles Davidson’s Wexford Capital, and Hal Mintz’ Sabby Capital.
An investor who dumped Anthera Pharmaceuticals (NASDAQ:ANTH) during the quarter was Howard Guberman’s Gruss Asset Management, which sold a position valued, at the end of March, at $2.56 million.
You can access the original SEC filing by clicking here.
Ownership Summary Table
|Name||Sole Voting Power||Shared Voting Power||Sole Dispositive Power||Shared Dispositive Power||Aggregate Amount Owned Power||Percent of Class|
|Biotechnology Value Trading Fund OS||0||0||0||0||0||0%|
|BVF Partners OS Ltd||0||0||0||0||0||0%|
|Mark N. Lampert||0||4,582,033||0||4,582,033||4,582,033||9.99%|
Page 1 of 14 – SEC Filing
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
Anthera Pharmaceuticals, Inc.
(Name of Issuer)
Common Stock, $0.001 par value
(Title of Class of Securities)
03674U 20 1
September 6, 2016
(Date of Event Which Requires Filing of this Statement)